Submit your Center of Excellence Application today!

Read More


Oct 15, 2019

AREDS2 formulation, Mediterranean diet and deep learning may improve diagnosis, treatment of AMD

SAN FRANCISCO —The AREDS2 formulation and a Mediterranean diet, especially fish, can help reduce the risk for patient progression to advanced age-related macular degeneration, while advancements in deep learning capabilities can improve ophthalmic diagnostic capabilities, according to a speaker here.

“The AREDS2 formulation is recommended to patients with intermediate or late AMD, and genetic testing is encouraged for research purposes but not for clinical care yet. Deep learning may help us in the future for more accurate and more efficient clinical practice but won’t replace us,” Emily Y. Chew, MD, said during the Jackson Memorial Lecture at the American Academy of Ophthalmology annual meeting.

The AREDS2 formulation, consisting of vitamin C, vitamin E, lutein/zeaxanthin, zinc and copper, is recommended for patients with intermediate or late AMD in one eye to reduce progression to advanced AMD. Additionally, a high adherence to the Mediterranean diet is associated with reduced risk for progression to late AMD by 25% to 40%, Chew said.

Chew noted fish is the component of the Mediterranean diet associated with a 31% decreased risk for progression to geographic atrophy.

However, patient genetics can also increase risks for AMD progression. Chew said patients with the presence of complement factor H exhibited a sevenfold increased risk for late AMD.

“Genetic testing may determine the pathways and help us identify patients at high risk of disease progression,” she said.

Deep learning systems may also improve diagnostic capabilities of AMD severity and progression risk. Chew and colleagues developed DeepSeeNet, a deep learning model for automatic classification of patient-based AMD severity. The deep learning model assessed features of AMD on color fundus photographs and classified severity of AMD using the AREDS simplified severity scale to predict the risk for late AMD progression…..

Read more:

Source: Healio

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.